TL;DR: As of June 13, you can sign up for a one-year Sam's Club membership

Mariah Carey dressed as 'Mean Girls' character Regina George for Halloween as she cuts two holes out of her top to recreate the famous bra scene from the 2004 classic.

Food ads have long made their subjects look bigger, juicier and crispier than they are in real life

Pfizer reported Tuesday a loss following a sharp fall in the sales of its Covid-19 vaccine and...

A study has shown that millions of women and girls experience debilitating periods, that even cause mental health problems. A survey of 3,000 women and girls in the UK aged 16 to 40 for the Wellbeing of Women charity found that 86 per cent had had mental health problems, such as depression, anxiety and mood changes, in relation to their period, Meanwhile, of those surveyed, 96 per cent had experienced period pain, with 59 per cent saying their pain was severe. 91 per cent had experienced heavy periods, with 49 per cent saying their bleeding was severe. Even though these are common symptoms in women and girls with gynaecological conditions such as endometriosis, adenomyosis, fibroids and polycystic ovary syndrome, the report found that 51 per cent of respondents felt their healthcare professional had failed to take their problems seriously, and 82 per cent said they needed better access to accurate information on period problems. A further one-third never seek medical help, and more than half say their symptoms are not taken seriously, despite other symptoms including pain, heavy bleeding and irregular cycles. Prof Dame Lesley Regan, the chair of Wellbeing of Women, said: “It’s simply unacceptable that anyone is expected to suffer with period symptoms that disrupt their lives, including taking time off school, work, or their caring responsibilities, all of which may result in avoidable mental health problems. “Periods should not affect women’s lives in this way. If they do, it can be a sign of a gynaecological condition that requires attention and ongoing support – not dismissal.” Wellbeing of Women has launched its “Just a Period” campaign, which Regan said aims to address “the many years of medical bias, neglect and stigma in women’s health”. This includes tips on how to get the most out of seeing your GP and what women should do if they feel they have been dismissed by health professionals. Responding to the findings, Dr Ranee Thakar, the president of the Royal College of Obstetricians and Gynaecologists, said: “All too often women are living with debilitating symptoms, waiting to receive support or treatment for far longer than they should. “Access to high-quality information and support about periods, gynaecological conditions and their symptoms is vital to ensuring that women and girls get the help that they need at the right time.” Caroline Nokes, the Conservative MP and chair of the women and equalities committee, which is conducting an inquiry into reproductive and gynaecological health, said: “There is a terrible phrase: ‘Well, it’s just a period, why are you making a fuss about that? Can’t you just get on with it?’ Yet many women and girls are experiencing horrendous period symptoms and gynaecological conditions. Endometriosis alone affects 1.5 million women in the UK and costs the economy £8.2bn. Now is the time for change.” Anneliese Dodds, the shadow secretary of state for women and equalities, said: “Over the past few years, we have opened up the conversation around the menopause, and now we need to see this change with periods as well.” Sign up to our free Indy100 weekly newsletter Have your say in our news democracy. Click the upvote icon at the top of the page to help raise this article through the indy100 rankings.

Is anyone loyal anymore? If we consult our makeup bags, we’d have to say absolutely not. Most of us use a lengthening mascara from one brand and a concealer from another, and never think twice about it. You probably bought them at different times, one while shopping for something else at Sephora and the other from LTK.

The $229.99 Amazon Fire Max 11 is the company’s priciest and most powerful tablet yet.

Amsterdam's sex workers Thursday protested against the transfer of their famed red light district to an out-of-town "erotic centre", in what is seen as part of...

Private aviation company Jetex is deploying sustainable aviation fuels, and making its terminals more sustainable.

Domino's Pizza has long been a holdout of using third-party delivery apps in the United States. But now, the pizza chain has struck a deal with one of the world's largest food delivery services.

Using existing drugs to treat cervical cancer before standard treatment could lead to a 35% reduction in the risk of relapse or death, a new study suggests. Researchers from the UCL Cancer Institute and UCLH looked into whether a short course of induction chemotherapy (IC), where a drug is used to destroy as many cancer cells as possible, before chemoradiation (CRT), could help with this. Here’s everything you need to know about the findings… What is cervical cancer? According to the NHS website, cervical cancer is a type of cancer found anywhere near the cervix – the opening between the vagina and the womb (uterus), which is also known as the neck of the womb. Most cervical cancers grow very slowly and are caused by an infection from specific types of human papillomavirus (HPV) and mostly affect women under the age of 45. According to Jo’s Cervical Cancer Trust, symptoms include vaginal bleeding that is unusual to you, changes to vaginal discharge, discomfort during sex and pain in your lower back or pelvis. Changes to cells can be spotted by a cervical screening, and then treated before they turn into cancer. There are around 3,200 new cases every year in the UK, with the five-year survival rate being around 70%, according to Cancer Research UK. CRT has been the standard treatment for cervical cancer patients since 1999, but even though there have been overall significant developments in radiation therapy techniques, up to 30% of people experience their cancer coming back. What did the research involve? Over a 10-year period, 500 patients who had been diagnosed with cervical cancer – that was large enough to see without a microscope but hadn’t spread to other parts of the body – took part in the Interlace trial at hospitals in the UK, Mexico, India, Italy and Brazil. Researchers looked into whether a short course of IC before CRT could reduce rates of relapse and death. What results were found? After five years, researchers discovered that 80% of the people who received a combination of chemotherapy and radiotherapy were alive, whilst 73% had not seen their cancer return or spread. A major benefit, according to researchers, is that it can be incorporated into standard of care treatment relatively quickly, because cheap, accessible and already-approved ingredients such as carboplatin and paclitaxel are needed for IC. “Our trial shows that this short course of additional chemotherapy delivered immediately before the standard CRT can reduce the risk of the cancer returning or death by 35%,” said Dr Mary McCormack, lead investigator of the trial from UCL Cancer Institute and UCLH. “This is the biggest improvement in outcome in this disease in over 20 years. “I’m incredibly proud of all the patients who participated in the trial; their contribution has allowed us to gather the evidence needed to improve treatment of cervical cancer patients everywhere. “We couldn’t have done this without the generous support of Cancer Research UK.” Why is the research important? Dr Iain Foulkes, executive director of research and innovation at Cancer Research UK, said: “Timing is everything when you’re treating cancer. The simple act of adding induction chemotherapy to the start of chemoradiation treatment for cervical cancer has delivered remarkable results in this trial. “A growing body of evidence is showing the value of additional rounds of chemotherapy before other treatments like surgery and radiotherapy in several other cancers. “Not only can it reduce the chances of cancer coming back, it can be delivered quickly using drugs already available worldwide. “We’re excited for the improvements this trial could bring to cervical cancer treatment and hope short courses of induction chemotherapy will be rapidly adopted in the clinic.”

Lewis Hamilton finished only 12th in opening practice for the Spanish Grand Prix. As Max Verstappen predictably set the pace for Red Bull at Barcelona’s Circuit de Catalunya, Hamilton ended the one-hour running 1.2 seconds behind the Dutchman. Sergio Perez finished second, seven tenths adrift of his Red Bull team-mate, with Esteban Ocon, fresh from his podium at last weekend’s Monaco Grand Prix, third for Alpine. Home favourite Fernando Alonso was sixth. Mercedes spent the first running of the weekend rooted to the bottom of the time sheets before late laps from George Russell, who finished two places and one tenth ahead of his team-mate, and Hamilton hauled them up the order. Hamilton admitted here on Thursday that Mercedes’ much-anticipated upgrade, which made its debut in Monaco a week ago, had not provided the magic fix he was hoping for. And on his new machine’s second outing, at a track where the Silver Arrows said they would obtain a greater understanding of their upgrades, the evidence suggests they are no closer to competing with the grid’s all-conquering team, or indeed, leapfrogging rivals Aston Martin and Ferrari. Verstappen has been in a class of one for much of the past 18 months and his dominance continued on Friday. He was the only man to break the 75-second barrier, a day after he made the ominous prediction that Red Bull could win all 16 remaining races. Nyck de Vries has endured a trying start to his Formula One career but the AlphaTauri driver finished fourth in first practice, a spot clear of Alpine’s Pierre Gasly, with Alonso, the 41-year-old Spaniard, the only other driver to finish within a second of Verstappen. British driver Lando Norris was 11th for McLaren, six places ahead of Oscar Piastri in the other McLaren. Second practice, which could be disrupted by rain, is due to start at 5pm local time (4pm BST). Read More Charity boss speaks out over ‘traumatic’ encounter with royal aide Ukraine war’s heaviest fight rages in east - follow live Fernando Alonso: Hamilton can win eighth title but Verstappen can break records Fernando Alonso: Aston Martin ‘will not give up’ in push for F1 triumph Concerns Monaco GP could be ‘left behind’ as Max Verstappen wins ‘boring race’